In the past thirty years, childhood obesity rates have risen significantly worldwide, affecting
over 340 million children in affluent nations. This surge is intricately tied to metabolic …

Non-alcoholic fatty liver disease (NAFLD) affects 5.5–10.3% of children worldwide, while in
obese individuals, it increases to almost 34%. Pediatric NAFLD is consistently associated …

Context Nonalcoholic fatty liver disease (NAFLD) is associated with insulin resistance (IR)
and predicts type 2 diabetes. Currently, it is uncertain whether NAFLD may directly cause IR …

Introduction Paediatric NAFLD is an increasing global health concern, which can be
effectively managed with early detection. Screening, using accurate, affordable, and …

Background: Recent studies in adult non-elderly and elderly individuals have reported a link
between nonalcoholic fatty liver disease (NAFLD) and sarcopenia. Nonetheless, whether …

Background Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in children and
adolescents, particularly those with obesity. NAFLD is considered a hepatic manifestation of …

Introduction Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease in
the pediatric population. It is a significant liver complication of obesity that also prominently …

Introduction Non-alcoholic fatty liver disease (NAFLD) is a multifaceted disease that includes
a wide spectrum of liver damage. The presence and the degree of fibrosis are considered …

Objective This study aimed to determine the clinical characteristics of obese pediatric non-
alcoholic fatty liver disease (NAFLD) in central China and verify the applicability of some …

Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in
children. While environmental factors are major contributors to early onset, children have …